Aspect Partners
EW icon

Aspect Partners’s Edwards Lifesciences EW Stock Holding History

Aspect Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$950 Hold
11
– – ﹤0.01% 587
2026
Q2 		$995 Hold
11
– – ﹤0.01% 575
2026
Q1 		$881 Buy
11
+1
+10% +$82 ﹤0.01% 613
2025
Q4 		$853 Buy
+10
New +$821 ﹤0.01% 646
2024
Q2 		– Sell
-12
Closed -$1.15K – 576
2024
Q1 		$1.15K Hold
12
– – ﹤0.01% 482
2023
Q4 		$915 Buy
+12
New +$835 ﹤0.01% 477

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One North America
Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Aspect Partners's EW Position: Q3 2026 in Review

Aspect Partners held its Edwards Lifesciences (EW) position steady in Q3 2026 at 11 shares worth $950. The position accounts for ﹤0.01% of the portfolio, ranked #587.

Aspect Partners first reported a position in EW in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.15K in Q1 2024. 326 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Aspect Partners held 11 shares of Edwards Lifesciences worth $950 as of Q3 2026.
  • Aspect Partners left its Edwards Lifesciences share count unchanged in Q3 2026.
  • Edwards Lifesciences made up ﹤0.01% of Aspect Partners's portfolio in Q3 2026, its #587 holding.
  • Aspect Partners first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 6 quarters since.
  • Aspect Partners's Edwards Lifesciences position peaked at $1.15K in Q1 2024.
  • 326 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.